polatuzumab vedotin
ItalyDrugs containing this active substance
-
Polivy is used for the treatment of diffuse large B-cell lymphoma in patients who have never received previous therapy, or in patients who have relapsed or have not improved after at least one therapy and for whom a stem cell transplant is not possible.
Form: powder for concentrate for infusion solution
Active substance Dosage polatuzumab vedotin - ATC: L01FX14
Manufacturer: ROCHE REGISTRATION GMBH